SEC Form 4 · accession 0001104659-16-095535
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred Altomari
Officer — Chief Executive Officer · Director
Period of report
Feb 8, 2016
Accepted (ET)
Feb 10, 2016 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2016 | M | 16,666 | — | A | 94,920 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $5.93 | Feb 8, 2016 | A | 100,000 | A | — | Feb 7, 2026 | Common Stock | 100,000 | 100,000 | D |
| Restricted Stock UnitsF1,F3 | — | Feb 8, 2016 | A | 50,000 | A | — | — | Common Stock | 50,000 | 50,000 | D |
| Restricted Stock UnitsF1,F3 | — | Feb 8, 2016 | M | 16,666 | D | — | — | Common Stock | 16,666 | 33,334 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2This option was granted on February 8, 2016. 25% of the shares subject to the stock option vest on February 8, 2017, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on February 8, 2020.
- F3The restricted stock units were granted on February 8, 2016 and vest as follows: 16,666 units vested and were delivered on the grant date, 16,667 units will vest and be delivered on February 8, 2017, and 16,667 units will vest and be delivered on February 8, 2018.